Bipolar disorder and medical comorbidities
DOI:
https://doi.org/10.25118/2236-918X-6-5-3Keywords:
Bipolar disorder, medical comorbidities, treatment monitoringAbstract
Bipolar disorder (BD) is associated with several general medical conditions, resulting in a significant increase in morbidity and mortality. Cardiovascular and metabolic diseases are the most commonly associated with BD, and there is significant evidence of the deleterious effects of some medications on the etiology and course of medical comorbidities. Moreover, there is recent evidence that BD per se, as well as recurrent episodes of the illness, may be associated with a higher incidence of physical
illnesses. Evaluation of the bipolar patient should include knowledge of individual and familial risk factors, clinical examination, subsidiary tests as indicated to each case and close monitoring of medication side effects on the patient’s overall health.
Downloads
Metrics
References
Fenn HH, Bauer MS, Alshuler L, Evans DR, Williford WO, Kilbourne AM, et al. Medical comorbidity and helath-related quality of life in bipolar disorder across the adult age span. J Aff ect Disord. 2005;86:47-60.
Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293:2528-30.
Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased Mortality among pati ents admitt ed with major psychiatric disorders: a registerbased study comparing mortality in unipolar depressive disorder, bipolar aff ecti ve disorder, schizoaff ecti ve disorder, and schizophrenia. J Clin Psychiatry. 2007;68:899-907.
Gomes FA. Comorbidades clínicas em psiquiatria. São Paulo: Atheneu; 2012.
Evans DL, Charney DS. Mood disorders and medial illness: a major public health problem. Biol Psychiatry. 2003;54:177-80.
Frye MA, Calabrese JR, Reed ML, Wagner KD, Lewis L, McNulty J, et al. Use of health care services among persons who screen positi ve for bipolar disorder. Psychiatr Serv. 2005;56:1529-33.
Guo JJ, Keck PE Jr, Li H, Jang R, Kelton CM. Treatment costs and health care uti lizati on for pati ents with bipolar disorder in a large managed care populati on. Value Health. 2008;11:416-23.
Zhao Z, Okusaga OO, Quevedo J, Soares JC, Teixeira AL. The potenti al associati on between obesity and bipolar disorder: a meta-analysis. J Aff ect Disord. 2016;202:120-3.
McElroy SL. Obesity in pati ents with severe mental illness: overview and management. J Clin Psychiatry. 2009;70:12-21.
Mansur RB, Brietzke E, McIntyre RS. Is there a “metabolic-mood syndrome”? A review of the relati onship between obesity and mood disorders. Neurosci Biobehav Rev. 2015;52:89-104.
Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in pati ents with bipolar I disorder. Am J Psychiatry. 2003;160:112-7.
Fagiolini A, Kupfer DJ, Rucci P, Scott JA, Novick DM, Frank E. Suicide att empts and ideati on in pati ents with bipolar I disorder. J Clin Psychiatry. 2004;65:509-14.
Wang PW, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, et al. Overweight and obesity in bipolar disorders. J Psychiatr Res. 2006;40:762-4.
Gomes FA, Kauer-Sant’Anna M, Magalhães PV, Jacka FN, Dodd S, Gama CS, et al. Obesity is associated with previous suicide att empts in bipolar disorder. Acta Neuropsychiatr. 2010;22:63-7.
Wildes JE, Marcus MD, Fagiolini A. Obesity in pati ents with bipolar disorder: a biopsychosocialbehavioral model. J Clin Psychiatry. 2006;67:904-15.
Calkin CV, Gardner DM, Ransom T, Alda M. The relati onship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med. 2013;45:171-81.
Gomes FA, Almeida KM, Magalhães PV, Caetano SC, Kauer-Sant’Anna M, Lafer B, et al. Cardiovascular risk factors in outpati ents with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder. Rev Bras Psiquiatr. 2013;35:126-30.
McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, eti ology, and treatment implicati ons. Ann Clin Psychiatry. 2005;17:83-93.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, et al. Metabolic syndrome and metabolic abnormaliti es in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013;170:265-74.
Musselman Dl, Evans DL, Nemeroff CB. The relati onship of depression to cardiovasculardisease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-92.
Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry. 2006;67:25-30; discussion 36-42.
Tsai SY, Lee CH, Kuo CJ, Chen CC. A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2005;66:1586-91.
Correll CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with secondgeneration antipsychotic drugs. J Clin Psychiatry. 2006;67:575-83.
Mackin P, Bishop D, Watkinson H, Gallagher P, Ferrier IN. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry. 2007;191:23-9.
Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007;68:917-23.
Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics. 2007;48:412-7.
McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes H, Law C, Miranda A, et al. Medical comorbidity in bipolar disorder: reprioritizing unmet needs. Curr Opin Psychiatry. 2007;20:406-16.
Chakrabarti S. Thyroid functions and bipolar affective disorder. J Thyroid Res. 2011;2011:306367.
Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study. PLoS Med. 2016;13:e1002058.
Ramasubbu R, Beaulieu S, Taylor VH, Schaffer A, McIntyre RS; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann Clin Psychiatry. 2012;24:82-90.
Cradock-O’Leary J, Young AS, Yano EM, Wang M, Lee ML. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv. 2002;53:874-8.
Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32:675-92.
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559-95.
Bermudes RA, Keck Jr PE, McElroy SL. Managing metabolic abnormalities in the psychiatrically ill. A clinical guide for psychiatrists. Arlington: American Psychiatric Publishing; 2007.
De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10:138-51.
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
